{
    "root": "bc5fe496-071b-4c25-95da-14c6c561e79e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sulfamethoxazole and Trimethoprim",
    "value": "20250226",
    "ingredients": [
        {
            "name": "SULFAMETHOXAZOLE",
            "code": "JE42381TNV",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9332"
        },
        {
            "name": "TRIMETHOPRIM",
            "code": "AN164J8Y0X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_45924"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        }
    ],
    "indications": {
        "text": "reduce development drug-resistant bacteria maintain effectiveness sulfamethoxazole trimethoprim tablets antibacterial drugs , sulfamethoxazole trimethoprim tablets used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy . urinary tract infections treatment urinary tract infections due susceptible strains following organisms : escherichia coli , klebsiella species , enterobacter species , morganella morganii , proteus mirabilis proteus vulgaris . recommended initial episodes uncomplicated urinary tract infections treated single effective antibacterial agent rather combination . acute otitis media treatment acute otitis media pediatric patients due susceptible strains streptococcus pneumoniae haemophilus influenzae judgment physician sulfamethoxazole trimethoprim offers advantage antimicrobial agents . date , limited data safety repeated sulfamethoxazole trimethoprim tablets pediatric patients two years age . sulfamethoxazole trimethoprim tablets indicated prophylactic prolonged otitis media age . acute exacerbations chronic bronchitis adults treatment acute exacerbations chronic bronchitis due susceptible strains streptococcus pneumoniae haemophilus influenzae physician deems sulfamethoxazole trimethoprim could offer advantage single antimicrobial agent . shigellosis treatment enteritis caused susceptible strains shigella flexneri shigella sonnei antibacterial therapy indicated . pneumocystis jirovecii pneumonia treatment documented pneumocystis jirovecii pneumonia prophylaxis p. jirovecii pneumonia individuals immunosuppressed considered increased risk developing p. jirovecii pneumonia . traveler \u2019 diarrhea adults treatment traveler \u2019 diarrhea due susceptible strains enterotoxigenic e. coli .",
        "doid_entities": [
            {
                "text": "otitis media (DOID:10754)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10754"
            },
            {
                "text": "chronic bronchitis (DOID:6132)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6132"
            },
            {
                "text": "shigellosis (DOID:12385)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12385"
            },
            {
                "text": "pneumocystis jirovecii pneumonia (DOID:11339)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11339"
            },
            {
                "text": "pneumonia (DOID:552)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_552"
            },
            {
                "text": "diarrhea (DOID:13250)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13250"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute otitis media",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_279888"
            }
        ]
    },
    "contraindications": {
        "text": "sulfamethoxazole trimethoprim contraindicated pediatric patients less 2 months age . urinary tract infections shigellosis adults pediatric patients , acute otitis media children adults : usual adult treatment urinary tract infections 1 sulfamethoxazole trimethoprim double strength tablet 2 sulfamethoxazole trimethoprim tablets every 12 hours 10 14 days . identical daily used 5 days treatment shigellosis . children : recommended dose children urinary tract infections acute otitis media 40 mg/kg sulfamethoxazole 8 mg/kg trimethoprim per 24 hours , given two divided doses every 12 hours 10 days . identical daily used 5 days treatment shigellosis . following table guideline attainment : children 2 months age older : weight dose \u2013 every 12 hours lb kg tablets 22 10 - 44 20 1 66 30 1\u00bd 88 40 2 1 ds tablet patients impaired renal function renal function impaired , reduced employed using following table : creatinine clearance ( ml/min ) recommended regimen 30 usual standard regimen 15 30 \u00bd usual regimen 15 recommended acute exacerbations chronic bronchitis adults usual adult treatment acute exacerbations chronic bronchitis 1 sulfamethoxazole trimethoprim double strength tablet , 2 sulfamethoxazole trimethoprim tablets every 12 hours 14 days . pneumocystis jirovecii pneumonia treatment adults children : recommended treatment patients documented pneumocystis jirovecii pneumonia 75 100 mg/kg sulfamethoxazole 15 20 mg/kg trimethoprim per 24 hours given equally divided doses every 6 hours 14 21 days12 . following table guideline upper limit : weight dose \u2013 every 6 hours lb kg tablets 18 8 - 35 16 1 53 24 1 \u00bd 70 32 2 1 ds tablet 88 40 2 \u00bd 106 48 3 1 \u00bd ds tablets 141 64 4 2 ds tablets 176 80 5 2 \u00bd ds tablets lower limit dose ( 75 mg/kg sulfamethoxazole 15 mg/kg trimethoprim per 24 hours ) administer 75 % dose table . prophylaxis adults : recommended prophylaxis adults 1 sulfamethoxazole trimethoprim double strength tablet daily13 . children : children , recommended dose 750 mg/m2/day sulfamethoxazole 150 mg/m2/day trimethoprim given orally equally divided doses twice day , 3 consecutive days per week . total daily dose exceed 1,600 mg sulfamethoxazole 320 mg trimethoprim14 . following table guideline attainment children : body surface area dose \u2013 every 12 hours ( m2 ) tablets 0.26 - 0.53 \u00bd 1.06 1 traveler \u2019 diarrhea adults treatment traveler \u2019 diarrhea , usual adult 1 sulfamethoxazole trimethoprim double strength tablet 2 sulfamethoxazole trimethoprim tablets every 12 hours 5 days .",
        "doid_entities": [
            {
                "text": "shigellosis (DOID:12385)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12385"
            },
            {
                "text": "otitis media (DOID:10754)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10754"
            },
            {
                "text": "chronic bronchitis (DOID:6132)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6132"
            },
            {
                "text": "pneumocystis jirovecii pneumonia (DOID:11339)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11339"
            },
            {
                "text": "pneumonia (DOID:552)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_552"
            },
            {
                "text": "diarrhea (DOID:13250)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13250"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute otitis media",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_279888"
            }
        ]
    },
    "warningsAndPrecautions": "sulfamethoxazole trimethoprim tablets , usp supplied follows : sulfamethoxazole trimethoprim tablets usp , ds ( double strength ) 800 mg/160 mg , supplied white , oval , bisected tablets debossed \u201c ip \u201d bisect \u201c 272 \u201d one side . available follows : bottles 10 : ndc 53746-272-11 bottles 24 : ndc 53746-272-24 bottles 100 : ndc 53746-272-01 bottles 250 : ndc 53746-272-02 bottles 500 : ndc 53746-272-05 sulfamethoxazole trimethoprim tablets usp , 400 mg/80 mg , supplied white , round , bisected tablets debossed \u201c ip \u201d \u201c 271 \u201d one side . available follows : bottles 50 : ndc 53746-271-50 bottles 100 : ndc 53746-271-01 bottles 500 : ndc 53746-271-05 bottles 1000 : ndc 53746-271-10 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container .",
    "adverseReactions": "sulfamethoxazole trimethoprim contraindicated following situations : known hypersensitivity trimethoprim sulfonamides history drug-induced immune thrombocytopenia trimethoprim and/or sulfonamides documented megaloblastic anemia due folate deficiency pediatric patients less 2 months age marked hepatic damage severe renal insufficiency renal function status monitored concomitant dofetilide ( ) .",
    "indications_original": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. \n                  \n                     \n                        Urinary Tract Infections \n                     \n                  \n                  For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and Proteus vulgaris. It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. \n                  \n                     \n                        Acute Otitis Media \n                     \n                  \n                  For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. To date, there are limited data on the safety of repeated use of sulfamethoxazole and trimethoprim tablets in pediatric patients under two years of age. Sulfamethoxazole and trimethoprim tablets are not indicated for prophylactic or prolonged administration in otitis media at any age. \n                  \n                     \n                        Acute Exacerbations of Chronic Bronchitis in Adults \n                     \n                  \n                  For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when a physician deems that sulfamethoxazole and trimethoprim could offer some advantage over the use of a single antimicrobial agent. \n                  \n                     \n                        Shigellosis \n                     \n                  \n                  For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated. \n                  \n                     \n                        \n                           Pneumocystis jirovecii \n                        \n                     \n                     \n                        Pneumonia \n                     \n                  \n                  For the treatment of documented Pneumocystis jirovecii pneumonia and for prophylaxis against P. jirovecii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing P. jirovecii pneumonia. \n                  \n                     \n                        Traveler\u2019s Diarrhea in Adults \n                     \n                  \n                  For the treatment of traveler\u2019s diarrhea due to susceptible strains of enterotoxigenic E. coli.",
    "contraindications_original": "Sulfamethoxazole and trimethoprim is contraindicated in pediatric patients less than 2 months of age.\n                  \n                  \n                     \n                        Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients, and Acute Otitis Media in Children\n                     \n                  \n                  \n                     Adults: The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim double strength tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 10 to 14 days. An identical daily dosage is used for 5 days in the treatment of shigellosis.\n                  \n                     Children: The recommended dose for children with urinary tract infections or acute otitis media is 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours for 10 days. An identical daily dosage is used for 5 days in the treatment of shigellosis. The following table is a guideline for the attainment of this dosage:\n                  \n                     Children 2 months of age or older:\n                  \n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Weight\n                              \n                           \n                           \n                              \n                                 Dose \u2013 every 12 hours\n                              \n                           \n                        \n                        \n                           \n                              \n                                 lb\n                              \n                           \n                           \n                              \n                                 kg\n                              \n                           \n                           \n                              \n                                 Tablets\n                              \n                           \n                        \n                        \n                           \n                              22\n                           \n                           \n                              10\n                           \n                           \n                              -\n                           \n                        \n                        \n                           \n                              44\n                           \n                           \n                              20\n                           \n                           \n                              1\n                           \n                        \n                        \n                           \n                              66\n                           \n                           \n                              30\n                           \n                           \n                              1\u00bd\n                           \n                        \n                        \n                           \n                              88\n                           \n                           \n                              40\n                           \n                           \n                              2 or 1 DS tablet\n                           \n                        \n                     \n                  \n                  \n                     \n                        For Patients with Impaired Renal Function \n                     \n                  \n                  When renal function is impaired, a reduced dosage should be employed using the following table: \n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Creatinine \n                              \n                              \n                                 Clearance (mL/min)\n                              \n                           \n                           \n                              \n                                 Recommended \n                              \n                              \n                                 Dosage Regimen\n                              \n                           \n                        \n                        \n                           \n                              Above 30\n                           \n                           \n                              Usual standard regimen\n                           \n                        \n                        \n                           \n                              15 to 30\n                           \n                           \n                              \u00bd the usual regimen\n                           \n                        \n                        \n                           \n                              Below 15\n                           \n                           \n                              Use not recommended\n                           \n                        \n                     \n                  \n                  \n                     \n                        Acute Exacerbations of Chronic Bronchitis in Adults\n                     \n                  \n                  The usual adult dosage in the treatment of acute exacerbations of chronic bronchitis is 1 sulfamethoxazole and trimethoprim double strength tablet, or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 14 days. \n                  \n                     \n                        \n                           Pneumocystis jirovecii\n                        \n                         Pneumonia \n                     \n                  \n                  \n                     \n                        Treatment \n                     \n                  \n                  \n                     Adults and Children:\n                  \n                  The recommended dosage for treatment of patients with documented Pneumocystis jirovecii pneumonia is 75 to 100 mg/kg sulfamethoxazole and 15 to 20 mg/kg trimethoprim per 24 hours given in equally divided doses every 6 hours for 14 to 21 days12. The following table is a guideline for the upper limit of this dosage: \n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Weight\n                              \n                           \n                           \n                              \n                                 Dose \u2013 every 6 hours\n                              \n                           \n                        \n                        \n                           \n                              \n                                 lb\n                              \n                           \n                           \n                              \n                                 kg\n                              \n                           \n                           \n                              \n                                 Tablets\n                              \n                           \n                        \n                        \n                           \n                              18\n                           \n                           \n                              8\n                           \n                           \n                              -\n                           \n                        \n                        \n                           \n                              35\n                           \n                           \n                              16\n                           \n                           \n                              1\n                           \n                        \n                        \n                           \n                              53\n                           \n                           \n                              24\n                           \n                           \n                              1 \u00bd \n                           \n                        \n                        \n                           \n                              70\n                           \n                           \n                              32\n                           \n                           \n                              2 or 1 DS tablet\n                           \n                        \n                        \n                           \n                              88\n                           \n                           \n                              40\n                           \n                           \n                              2 \u00bd \n                           \n                        \n                        \n                           \n                              106\n                           \n                           \n                              48\n                           \n                           \n                              3 or 1 \u00bd DS tablets\n                           \n                        \n                        \n                           \n                              141\n                           \n                           \n                              64\n                           \n                           \n                              4 or 2 DS tablets\n                           \n                        \n                        \n                           \n                              176\n                           \n                           \n                              80\n                           \n                           \n                              5 or 2 \u00bd DS tablets\n                           \n                        \n                     \n                  \n                  For the lower limit dose (75 mg/kg sulfamethoxazole and 15 mg/kg trimethoprim per 24 hours) administer 75% of the dose in the above table. \n                  \n                     \n                        Prophylaxis \n                     \n                  \n                  \n                     Adults: \n                  \n                  The recommended dosage for prophylaxis in adults is 1 sulfamethoxazole and trimethoprim double strength tablet daily13.\n                  \n                     Children:\n                  \n                  For children, the recommended dose is 750 mg/m2/day sulfamethoxazole with 150 mg/m2/day trimethoprim given orally in equally divided doses twice a day, on 3 consecutive days per week. The total daily dose should not exceed 1,600 mg sulfamethoxazole and 320 mg trimethoprim14. The following table is a guideline for the attainment of this dosage in children:\n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Body Surface Area\n                              \n                           \n                           \n                              \n                                 Dose \u2013 every 12 hours\n                              \n                           \n                        \n                        \n                           \n                              \n                                 (m2)\n                              \n                           \n                           \n                              \n                                 Tablets\n                              \n                           \n                        \n                        \n                           \n                              0.26\n                           \n                           \n                              -\n                           \n                        \n                        \n                           \n                              0.53\n                           \n                           \n                              \u00bd\n                           \n                        \n                        \n                           \n                              1.06\n                           \n                           \n                              1\n                           \n                        \n                     \n                  \n                  \n                     \n                        Traveler\u2019s Diarrhea in Adults\n                     \n                  \n                  For the treatment of traveler\u2019s diarrhea, the usual adult dosage is 1 sulfamethoxazole and trimethoprim double strength tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 5 days.",
    "warningsAndPrecautions_original": "Sulfamethoxazole and Trimethoprim Tablets, USP are supplied as follows: \n                  Sulfamethoxazole and Trimethoprim Tablets USP, DS (double strength) 800 mg/160 mg, are supplied as white, oval, bisected tablets debossed \u201cIP\u201d bisect \u201c272\u201d on one side.\n                  They are available as follows:\n                  Bottles of 10:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-272-11\n                  Bottles of 24:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-272-24\n                  Bottles of 100:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-272-01\n                  Bottles of 250:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-272-02\n                  Bottles of 500:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-272-05\n                  Sulfamethoxazole and Trimethoprim Tablets USP, 400 mg/80 mg, are supplied as white, round, bisected tablets debossed \u201cIP\u201d over \u201c271\u201d on one side.\n                  They are available as follows:\n                  Bottles of 50:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-271-50\n                  Bottles of 100:\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 53746-271-01\n                  Bottles of 500:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-271-05\n                  Bottles of 1000:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 53746-271-10\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. \n                  DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER.",
    "adverseReactions_original": "Sulfamethoxazole and trimethoprim is contraindicated in the following situations:\n                  \n                     known hypersensitivity to trimethoprim or sulfonamides\n                     history of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides\n                     documented megaloblastic anemia due to folate deficiency\n                     pediatric patients less than 2 months of age\n                     marked hepatic damage\n                     severe renal insufficiency when renal function status cannot be monitored\n                     concomitant administration with dofetilide (see \n                           PRECAUTIONS\n                        ).",
    "drug": [
        {
            "name": "Sulfamethoxazole and Trimethoprim",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9332"
        }
    ]
}